Eyes On Pricing As Zolgensma Moves Closer To Japan Market

Possible May Launch?

Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.

Gene therapy
Zolgensma To Be Second Product For SMA In Japan • Source: Shutterstock

More from Japan

More from Focus On Asia